SCHEMBL6574077

SCHEMBL6574077

C=CC(OCC(CN)c1ccccc1)c1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GABBR2 O75899 2/20 0.42
GABBR1 Q9UBS5 2/20 0.42
TAAR1 Q96RJ0 4/20 0.39
HTR2A P28223 3/20 0.39
CASR P41180 1/20 0.39
CYP1A2 P05177 2/20 0.38
CYP2D6 P10635 2/20 0.38
PKM P14618 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
HRH1 P35367 2/20 0.35
CHRNB2 P17787 2/20 0.34
CHRNA4 P43681 2/20 0.34
CYP3A4 P08684 1/20 0.33
CYP2C9 P11712 1/20 0.33
TSHR P16473 1/20 0.33
SLC6A4 P31645 1/20 0.33
CYP2C19 P33261 1/20 0.33
SLC6A3 Q01959 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14453825 0.75 TAAR1 (0.50) GABBR2GABBR1TAAR1HTR2ACYP1A2
SCHEMBL6931929 0.73 CASR (0.49) CASRCYP1A2NPSR1TSHRCYP2C19
SCHEMBL1906076 0.73 MEN1 (0.44) TAAR1HTR2ACASRCYP2D6SMN1; SMN2
SCHEMBL20241505 0.73 CASR (0.37) TAAR1HTR2ACASRCYP1A2CYP2D6
SCHEMBL7158465 0.73 CASR (0.40) TAAR1HTR2ACASRCYP1A2CYP2D6
SCHEMBL11434362 0.73 CASR (0.40) HTR2ACASRCYP1A2CYP2D6SMN1; SMN2
SCHEMBL17075263 0.72 CASR (0.46) CASRCYP1A2CYP2D6PKMSMN1; SMN2
SCHEMBL16617907 0.72 CASR (0.48) CASRCYP2D6PKMSMN1; SMN2NPSR1
SCHEMBL18642721 0.72 GABBR2 (0.47) GABBR2GABBR1TAAR1HTR2ACYP1A2
SCHEMBL793949 0.72 SLC6A2 (0.44) CASRCYP1A2CYP2D6SMN1; SMN2CHRNB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1154983-B1 NOVEL SUBSTITUTED 3-PHENOXY AND 3-PHENYLALKYLOXY-2-PHENYL-PROPYLAMINES BOEHRINGER INGELHEIM PHARMA (DE) 2004-04-28 EP disclosed
EP-1154983-B1 NOVEL SUBSTITUTED 3-PHENOXY AND 3-PHENYLALKYLOXY-2-PHENYL-PROPYLAMINES BOEHRINGER INGELHEIM PHARMA (DE) 2004-04-28 EP disclosed
US-6441237-B1 DRUGS; ANTIARRHTHYMIA AGENTS, ANTIISCHEMIC AGENTS BOEHRINGER INGELHEIM PHARMA KG (DE) 2002-08-27 US disclosed
US-6441237-B1 DRUGS; ANTIARRHTHYMIA AGENTS, ANTIISCHEMIC AGENTS BOEHRINGER INGELHEIM PHARMA KG (DE) 2002-08-27 US disclosed
US-6441237-B1 DRUGS; ANTIARRHTHYMIA AGENTS, ANTIISCHEMIC AGENTS BOEHRINGER INGELHEIM PHARMA KG (DE) 2002-08-27 US disclosed
EP-1154983-A1 NOVEL SUBSTITUTED 3-PHENOXY AND 3-PHENYLALKYLOXY-2-PHENYL-PROPYLAMINES Boehringer Ingelheim Pharma KG (DE) 2001-11-21 EP disclosed
EP-1154983-A1 NOVEL SUBSTITUTED 3-PHENOXY AND 3-PHENYLALKYLOXY-2-PHENYL-PROPYLAMINES Boehringer Ingelheim Pharma KG (DE) 2001-11-21 EP disclosed
WO-2000048987-A1 NOVEL SUBSTITUTED 3-PHENOXY AND 3-PHENYLALKYLOXY-2-PHENYL-PROPYLAMINES BOEHRINGER INGELHEIM PHARMA KG (DE) 2000-08-24 WO disclosed
WO-2000048987-A1 NOVEL SUBSTITUTED 3-PHENOXY AND 3-PHENYLALKYLOXY-2-PHENYL-PROPYLAMINES BOEHRINGER INGELHEIM PHARMA KG (DE) 2000-08-24 WO disclosed